Navigation Links
Cowen Healthcare Royalty Partners Raises $1 Billion
Date:1/5/2012

STAMFORD, Conn., Jan. 5, 2012 /PRNewswire/ -- Cowen Healthcare Royalty Partners (Cowen Royalty), a global healthcare investment firm, today announced the closing of Cowen Healthcare Royalty Partners II, L.P. (CHRP II).  With approximately $1 billion in new capital commitments, Cowen Royalty will sustain its broad strategy of investing in traditional passive royalties, Synthetic royalties® and structured financings. Cowen Royalty exceeded the initial target for CHRP II by more than 75 percent.

"With a large amount of fresh capital and a healthy pipeline of financing opportunities and royalty asset sales, we believe we are well positioned to capitalize on this growing multi-billion dollar market opportunity," commented Clarke B. Futch, Founding Managing Director at Cowen Royalty.

Similar to its first fund, Cowen Royalty will target investments between $20MM-$100MM in the U.S., Europe and Asia.  The two main categories for capital investments include commercial stage biopharmaceutical and medical device companies in need of growth capital, and universities/inventors looking to monetize product interests.

"Increased demand for alternatives to traditional debt or equity by both companies and royalty owners will continue to drive this finance category going forward," further commented Cowen Royalty Founding Managing Director Todd C. Davis.

Since raising CHRP I in 2008, Cowen Royalty has made a total of 20 investments in 17 products including Lexiva® (GlaxoSmithKline), Cetrotide® (Merck Serono), Myozyme® (Genzyme, a Sanofi Company), Qutenza® (Astellas Pharma), Oracea® (Galderma) and KAMRA® inlay (AcuFocus). During the second half of 2011, Cowen Royalty closed eight (8) deals including product focused investments with Dyax Corp (DYAX), Stereotaxis, Inc. (STXS) and Zogenix (ZGNX), and royalty monetizations with several universities.  The Firm has continued to strengthen its team, adding experienced investment, financial, legal and operations professionals under the leadership of co-founders Gregory B. Brown, M.D., Todd C. Davis and Clarke B. Futch.

In addition to existing Cowen Royalty limited partners, CHRP II LP's consist of a world-class list of public and corporate pension funds, financial institutions, insurance companies, funds-of-funds and university endowments.

Credit Suisse Securities (USA) LLC acted as exclusive financial advisor/placement agent and Goodwin Procter LLP as legal counsel.

About Cowen Healthcare Royalty Partners

Founded in 2007, Cowen Healthcare Royalty Partners is a global healthcare investment firm with over $1.5 billion of capital under management. The Firm specializes in structured financing solutions for the life sciences industry. For more information, visit www.cowenroyalty.com.

Media Contact:         

Kellie Walsh
914-315-6072
kwalsh@kwmcommunications.com

 


'/>"/>
SOURCE Cowen Healthcare Royalty Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
2. BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care Conference
3. Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
4. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
5. Cempra Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
6. Life Technologies to Present at the Cowen and Company 31st Annual Health Care Conference
7. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
8. Savient to Present at the Cowen and Company 30th Annual Health Care Conference
9. Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
10. RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
11. Amgen to Present at the Cowen and Company Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
Breaking Biology Technology:
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):